Who We Are:
The Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation is composed of a group of physicians with clinical expertise in caring for patients with leukemias and MDS, lymphomas, and plasma disorders like myeloma. While being superior care givers, the physicians in the division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation are also motivated every day to passionately pursue research for better life-saving and life-enhancing outcomes for their patients.
Why We Need Your Support:
Support of the Hematologic Malignancies Division ensures that our researchers and clinicians have the funds necessary to support our efforts in patient care, patient and physician education, clinical trials and basic science for all the blood cancers we treat.